SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-040885
Filing Date
2024-02-21
Accepted
2024-02-21 10:10:30
Documents
16
Period of Report
2024-02-21
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d781705d8k.htm   iXBRL 8-K 25129
2 EX-99.1 d781705dex991.htm EX-99.1 10648
6 GRAPHIC g781705dsp_1bb.jpg GRAPHIC 9090
  Complete submission text file 0001193125-24-040885.txt   171066

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA vcnx-20240221.xsd EX-101.SCH 2841
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE vcnx-20240221_lab.xml EX-101.LAB 17235
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vcnx-20240221_pre.xml EX-101.PRE 10806
18 EXTRACTED XBRL INSTANCE DOCUMENT d781705d8k_htm.xml XML 3533
Mailing Address 1895 MOUNT HOPE AVE ROCHESTER NY 14620
Business Address 1895 MOUNT HOPE AVE ROCHESTER NY 14620 585-271-2700
VACCINEX, INC. (Filer) CIK: 0001205922 (see all company filings)

IRS No.: 161603202 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38624 | Film No.: 24656714
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)